SA medical marijuana company Cilo Cybin is considering more assets and even a US stock exchange listing

Cilo Cybin CEO Gabriel Theron says that while some may initially “laugh” at the group’s small size compared to the JSE, it expects to grow and perhaps even list on a US stock exchange. (Cilo Cybin/included)

Now that a listing date has been set on AltX, Cilo Cybin Holdings is targeting significant future growth through new acquisitions in the biotech and medical cannabis sectors in the near term.

In an interview with News24 on Friday, CEO and founder Gabriel Theron said some may “laugh” at Cilo Cybin’s initially small market capitalization of R70 million when it goes public on June 25 as a special purpose acquisition company (SPAC).

However, the bigger picture is about the development opportunities that listing offers. Following the first acquisition, the group plans to move into general management and then consider acquisitions of other branded products and distribution businesses, both locally and abroad.